Patent Drafting and Prosecution
About
Transforming innovation into assets
A strategic plan is key to building a strong patent portfolio. If your patent is challenged, will it withstand those rigors and remain an asset, or will it become a liability?
Contacts
- Eric P. Raciti
- Partner
- Boston, MA
- +1 617 646 1675
Experience
Finnegan is lead and preferred IP transactions counsel for one of the largest pharmaceutical companies in the world, handling more than 50 diligence projects each year, including all IP and related transactional aspects of the matters. The transactions span the full gamut of technologies from small molecule through biologics such as antibodies, oligonucleotides, and gene therapies. Finnegan also provides extensive assistance with post-deal integration procedures and subsequent global prosecution and portfolio strategy, ensuring a seamless transition of IP assets to the company and maximum value from acquired IP.
Finnegan is lead and preferred IP strategy counsel for one of the largest pharmaceutical companies in the world, handling all aspects of prosecution and portfolio management for multiple top-tier products for the client. The work spans the gamut from drafting and prosecution through larger strategic planning, patent term extension, and pre-litigation preparation on blockbuster small molecule and biologic products in the oncology, rheumatology, immunology, neuromuscular, and cell and gene therapy spaces.
Finnegan is proud to partner with CentralSquare in developing and protecting its mission-critical software and technology solutions for public sector agencies, including those serving public safety and public administration. Our team has led the drafting and prosecution of a broad portfolio of artificial intelligence (AI)-related patent applications, advancing CentralSquare’s innovations across emergency services and municipal operations. These AI technologies accelerate emergency response, streamline workflows, and strengthen data-driven decision-making for agencies and the communities they serve.
Working closely with CentralSquare’s inventors and in-house counsel, we ensure every application captures the technical depth of the invention while aligning with CentralSquare’s strategic goals. We prioritize clarity, enforceability, and foresight—refining claims, anticipating examiner challenges, and crafting robust Office Action responses. By anticipating industry trends in AI and preparing forward-looking applications, Finnegan positions CentralSquare’s innovations not only to be protected, but to drive lasting impact in public safety and beyond.
Finnegan supports Megagon Labs with developing its patent portfolio directed to cutting edge artificial intelligence (AI) technologies and assists with open-source licensing matters.
